Kevin Fitzgerald

Role
Chief Scientific Officer at Alnylam Pharmaceuticals
Location
Brookline, MA, US
LinkedIn followers
500 followers
Research & DevelopmentView LinkedIn profile

About Kevin Fitzgerald

Patient-centric executive with 23 year career marked by developing drugs that impact…

Experience

  1. Chief Scientific Officer

    Alnylam Pharmaceuticals

    Dec 2018 — Present

    Promoted from Director, Senior Director, Vice President, SVP, CSO. Currently leading an innovative and diverse Research Department of >100. Responsible for all aspects of novel drug development including chemistry, screening, lead identification, technology platform, preclinical, clinical POC, portfolio development and culture. Multiple successful business and drug development alliances. Key Achievements: •Led cross-functional teams to discover, refine, and advance two liver-based siRNA delivery systems from invention to clinic. •Inventor/co-inventor on over 50 patents including three novel FDA approved RNAi therapeutic products, and a large pipeline of potential therapeutics undergoing clinical trials •Played key role in forming ~$2 billion in transformative alliance deals (Genzyme/Sanofi and Regeneron) •Lead teams that delivered 4 CTA filings in 24 months by identifying, vetting, and executing on pipeline goals targeting four different genetically validated diseases. All four compounds rapidly achieved positive Phase 1 results and 3/4 are now approved while the other continues in development. Several were awarded FDA breakthrough and/or Orphan Drug status.

Skills

  • Life Sciences
  • Antibodies
  • Drug Discovery
  • Biochemistry
  • In Vivo
  • Cell Biology
  • Toxicology
  • Rnai
  • Cross-Functional Team Leadership
  • Clinical Research
  • Pharmaceutical Industry
  • Cell
  • Clinical Trials
  • Leadership
  • Lifesciences
  • Genomics
  • Chromatography
  • Biomarkers
  • Protein Chemistry
  • Genetics
  • Oncology
  • Sirna
  • Biotechnology
  • Clinical Development
  • Drug Development
  • Molecular Biology

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Kevin Fitzgerald — Chief Scientific Officer at Alnylam Pharmaceuticals in Brookline, MA, US | Unifers